ClinicalTrials.Veeva

Menu
W

Western Sky Medical Research | El Paso, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Remibrutinib
Ciclesonide
azelastine hydrochloride
CNP-201
Omalizumab
LOU064
HFA
Fluticasone Propionate
EVO756
budesonide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 40 total trials

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) (EMBARQ-CSU2)

The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urtic...

Enrolling
Chronic Spontaneous Urticaria
Biological: Matching placebo
Biological: barzolvolimab

This is a Phase 3, parallel group, placebo-controlled, double-blind, confirmatory study in patients with CINDU, with an optional Open-label Extension...

Enrolling
Chronic Inducible Urticaria
Drug: Remibrutinib
Other: Placebo

The purpose of this extension study is to collect long-term efficacy, safety and tolerability data on remibrutinib in a selected group of participant...

Active, not recruiting
Chronic Spontaneous Urticaria
Drug: LOU064 (blinded)
Drug: Placebo

This is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, saf...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Lunsekimig

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condition where the air...

Enrolling
Asthma
Drug: dupilumab
Drug: Matching Placebo

This clinical research study investigates the safety, tolerability and efficacy of a peanut SLIT-tablet in adults, adolescents, and children with pea...

Enrolling
Peanut Allergy
Other: Placebo
Biological: Peanut SLIT-tablet
Status recently updated

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe chronic spontaneous urticaria (CSU).

Not yet enrolling
Enrolling
Chronic Spontaneous Urticaria
Drug: EVO756
Drug: Placebo control

Trial sponsors

Novartis logo
Sumitomo Pharma logo
A
Meda Pharmaceuticals logo
C
Novartis logo
A
Celldex Therapeutics logo
C
E

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems